RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

85 hedge funds and large institutions have $755M invested in Revance Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 11 closing their positions.

Holders
85
Holders Change
-1
Holders Change %
-1.16%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
32
Reduced
28
Closed
11
Calls
$728K
Puts
$700K
Net Calls
+$28K
Net Calls Change
+$161K
Name Market Value Shares Shares
Change
Shares
Change %
FPFS
76
First Personal Financial Services
North Carolina
$22K 808 +808 New
CG
77
Cutler Group
California
$16K 600 -1,616 -73%
Zurich Cantonal Bank
78
Zurich Cantonal Bank
Switzerland
$10K 380
Citigroup
79
Citigroup
New York
$8K 277 +37 +15%
WAS
80
Winch Advisory Services
Wisconsin
$6K 200
CAPTRUST Financial Advisors
81
CAPTRUST Financial Advisors
North Carolina
$6K 200 +200 New
SIM
82
Sonora Investment Management
Arizona
$5.51K 200 +200 New
RE
83
RBC Europe
United Kingdom
$5.51K 200 +200 New
BRC
84
Bell Rock Capital
Delaware
$3K 100
QCG
85
Quadrant Capital Group
Ohio
$2K 103
PC
86
PointState Capital
New York
-438,200 Closed
GTC
87
Ghost Tree Capital
New York
-89,295 Closed
PAM
88
Paradigm Asset Management
New York
-17,600 Closed
Millennium Management
89
Millennium Management
New York
-17,471 Closed
Adage Capital Partners
90
Adage Capital Partners
Massachusetts
-12,183 Closed
TI
91
Trexquant Investment
Connecticut
-8,766 Closed
IA
92
IFP Advisors
Florida
-1,250 Closed
Creative Planning
93
Creative Planning
Kansas
-1,000 Closed
PAM
94
Panagora Asset Management
Massachusetts
-391 Closed
HNB
95
Huntington National Bank
Ohio
-236 Closed
Envestnet Asset Management
96
Envestnet Asset Management
Illinois
-27 Closed
Wolverine Trading
97
Wolverine Trading
Illinois
Citadel Advisors
98
Citadel Advisors
Florida